The latest study on Age Related Macular Degeneration (AMD) Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Age Related Macular Degeneration (AMD) Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Age Related Macular Degeneration (AMD) and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Bayer
F. HoffmannLa Roche
Regeneron
Novartis
Valeant
Pfizer
Age Related Macular Degeneration (AMD) Market Analysis By Type Segment:
Wet AMD
Dry AMD
Age Related Macular Degeneration (AMD) Market Analysis By Application Segment:
Men
Woman
Age Related Macular Degeneration (AMD) Market Analysis By Regions (Countries):
The Age Related Macular Degeneration (AMD) Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Age Related Macular Degeneration (AMD) Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Age Related Macular Degeneration (AMD) Market:
Age Related Macular Degeneration (AMD) market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Age Related Macular Degeneration (AMD) Market status and future forecast.
To present the key Age Related Macular Degeneration (AMD) Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2016-2027)
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age Related Macular Degeneration (AMD) Market Share by Application (2016-2027)
1.5.2 Men
1.5.3 Woman
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Age Related Macular Degeneration (AMD) Market Size
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Regions
2.2.1 Age Related Macular Degeneration (AMD) Market Size by Regions (2016-2027)
2.2.2 Age Related Macular Degeneration (AMD) Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Age Related Macular Degeneration (AMD) Market Size by Manufacturers
3.1.1 Global Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2020)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturers (2020)
3.1.3 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.2 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.3 Key Players Age Related Macular Degeneration (AMD) Product/Solution/Service
3.4 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020)
4.2 Global Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020)
5 United States
5.1 United States Age Related Macular Degeneration (AMD) Market Size (2016-2020)
5.2 Age Related Macular Degeneration (AMD) Key Players in United States
5.3 United States Age Related Macular Degeneration (AMD) Market Size by Type
5.4 United States Age Related Macular Degeneration (AMD) Market Size by Application
6 Europe
6.1 Europe Age Related Macular Degeneration (AMD) Market Size (2016-2020)
6.2 Age Related Macular Degeneration (AMD) Key Players in Europe
6.3 Europe Age Related Macular Degeneration (AMD) Market Size by Type
6.4 Europe Age Related Macular Degeneration (AMD) Market Size by Application
7 China
7.1 China Age Related Macular Degeneration (AMD) Market Size (2016-2020)
7.2 Age Related Macular Degeneration (AMD) Key Players in China
7.3 China Age Related Macular Degeneration (AMD) Market Size by Type
7.4 China Age Related Macular Degeneration (AMD) Market Size by Application
8 Japan
8.1 Japan Age Related Macular Degeneration (AMD) Market Size (2016-2020)
8.2 Age Related Macular Degeneration (AMD) Key Players in Japan
8.3 Japan Age Related Macular Degeneration (AMD) Market Size by Type
8.4 Japan Age Related Macular Degeneration (AMD) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Age Related Macular Degeneration (AMD) Market Size (2016-2020)
9.2 Age Related Macular Degeneration (AMD) Key Players in Southeast Asia
9.3 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type
9.4 Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application
10 India
10.1 India Age Related Macular Degeneration (AMD) Market Size (2016-2020)
10.2 Age Related Macular Degeneration (AMD) Key Players in India
10.3 India Age Related Macular Degeneration (AMD) Market Size by Type
10.4 India Age Related Macular Degeneration (AMD) Market Size by Application
11 Central & South America
11.1 Central & South America Age Related Macular Degeneration (AMD) Market Size (2016-2020)
11.2 Age Related Macular Degeneration (AMD) Key Players in Central & South America
11.3 Central & South America Age Related Macular Degeneration (AMD) Market Size by Type
11.4 Central & South America Age Related Macular Degeneration (AMD) Market Size by Application
12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Age Related Macular Degeneration (AMD) Introduction
12.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2020)
12.1.5 Bayer Recent Development
12.2 F. HoffmannLa Roche
12.2.1 F. HoffmannLa Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Age Related Macular Degeneration (AMD) Introduction
12.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2020)
12.2.5 F. HoffmannLa Roche Recent Development
12.3 Regeneron
12.3.1 Regeneron Company Details
12.3.2 Company Description and Business Overview
12.3.3 Age Related Macular Degeneration (AMD) Introduction
12.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2020)
12.3.5 Regeneron Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Age Related Macular Degeneration (AMD) Introduction
12.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2020)
12.4.5 Novartis Recent Development
12.5 Valeant
12.5.1 Valeant Company Details
12.5.2 Company Description and Business Overview
12.5.3 Age Related Macular Degeneration (AMD) Introduction
12.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2020)
12.5.5 Valeant Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Age Related Macular Degeneration (AMD) Introduction
12.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2020)
12.6.5 Pfizer Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Age Related Macular Degeneration (AMD) Key Market Segments
Table Key Players Age Related Macular Degeneration (AMD) Covered
Table Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type 2016-2027
Figure Wet AMD Figures
Table Key Players of Wet AMD
Figure Dry AMD Figures
Table Key Players of Dry AMD
Table Global Age Related Macular Degeneration (AMD) Market Size Growth by Application 2016-2027 (Million US$)
Figure Men Case Studies
Figure Woman Case Studies
Figure Age Related Macular Degeneration (AMD) Report Years Considered
Table Global Age Related Macular Degeneration (AMD) Market Size 2016-2027 (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions 2016-2027 (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions 2016-2020 (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Share by Regions 2016-2020
Figure Global Age Related Macular Degeneration (AMD) Market Share by Regions 2016-2020
Figure Global Age Related Macular Degeneration (AMD) Market Share by Regions 2020
Table Market Top Trends
Table Global Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2020) (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Share by Manufacturers (2020)
Figure Global Age Related Macular Degeneration (AMD) Market Share by Manufacturers in 2020
Table Global Age Related Macular Degeneration (AMD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Age Related Macular Degeneration (AMD) Product/Solution/Service
Table Date of Enter into Age Related Macular Degeneration (AMD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size Share by Type (2016-2020)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2016-2020)
Table Global Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Global Age Related Macular Degeneration (AMD) Market Size Share by Application (2016-2020)
Figure Global Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2016-2020)
Figure Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2020
Figure United States Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table United States Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table United States Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table United States Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table United States Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table United States Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table United States Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Europe Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Europe Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table Europe Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table Europe Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Europe Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Europe Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Europe Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure China Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table China Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table China Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table China Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table China Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table China Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table China Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Japan Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Japan Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table Japan Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table Japan Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Japan Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Japan Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Japan Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table Southeast Asia Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure India Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table India Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table India Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table India Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table India Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table India Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table India Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Figure Central & South America Age Related Macular Degeneration (AMD) Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Age Related Macular Degeneration (AMD) Revenue (2020) (Million US$)
Table Central & South America Key Players Age Related Macular Degeneration (AMD) Market Share (2020)
Table Central & South America Age Related Macular Degeneration (AMD) Market Size by Type (2016-2020) (Million US$)
Table Central & South America Age Related Macular Degeneration (AMD) Market Share by Type (2016-2020)
Table Central & South America Age Related Macular Degeneration (AMD) Market Size by Application (2016-2020) (Million US$)
Table Central & South America Age Related Macular Degeneration (AMD) Market Share by Application (2016-2020)
Table Bayer Company Details
Table Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2020) (Million US$)
Figure Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2020)
Table Bayer Recent Development
Table F. HoffmannLa Roche Company Details
Table F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2020)(Million US$)
Figure F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2020)
Table F. HoffmannLa Roche Recent Development
Table Regeneron Company Details
Table Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2020)(Million US$)
Figure Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2020)
Table Regeneron Recent Development
Table Novartis Company Details
Table Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2020)(Million US$)
Figure Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2020)
Table Novartis Recent Development
Table Valeant Company Details
Table Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2020)(Million US$)
Figure Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2020)
Table Valeant Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2020)(Million US$)
Figure Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2020)
Table Pfizer Recent Development
Table Global Age Related Macular Degeneration (AMD) Market Size by Regions (Million US$) 2021-2027
Figure Global Age Related Macular Degeneration (AMD) Market Size Share by Regions (2021-2027)
Figure Global Age Related Macular Degeneration (AMD) Market Size Share by Regions in 2027
Figure United States Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Europe Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure China Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Japan Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure India Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2027)(Million USD)
Table Global Age Related Macular Degeneration (AMD) Market Size by Product (2021-2027) (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Product (2021-2027)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Product in 2027
Table Global Age Related Macular Degeneration (AMD) Market Size by Application (2021-2027) (Million US$)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Application (2021-2027)
Figure Global Age Related Macular Degeneration (AMD) Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources